524703 — Sandu Pharmaceuticals Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapSuper Stock

Annual income statement for Sandu Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	655	653	673	672	699
Cost of Revenue
Gross Profit	298	342	347	351	384
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	632	634	656	651	676
Operating Profit	23.4	19.7	17.1	20.9	23.2
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	23.2	22.2	20.7	21.6	26.6
Provision for Income Taxes
Net Income After Taxes	15.9	15.2	14.6	15.5	17.7
Net Income Before Extraordinary Items
Net Income	15.9	15.2	14.6	15.5	17.7
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	15.9	15.2	14.6	15.5	17.7
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.87	1.61	1.51	1.6	1.83
Dividends per Share